by Sam Eskandari | Sep 28, 2018 | News
September 28, 2018, Vancouver, B.C. – Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas” or the “Company”) is pleased to announce that it has entered into a Memorandum of Understanding (“MOU”) with Agrima Botanicals Corp (“Agrima”) where both...
by Sam Eskandari | Sep 27, 2018 | News
September 20, 2018, Vancouver, B.C. – Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas” or the “Company”) is pleased to announce a non-brokered private placement offering of 13,157,900 at $0.19 per Unit raising up to $2,500,000 with no share...
by Sam Eskandari | Sep 19, 2018 | News
VANCOUVER, British Columbia, Sept. 19, 2018 (GLOBE NEWSWIRE) — Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas” or the “Company”) is pleased to provide a corporate update on its activities, milestones over the first three quarters of...
by Sam Eskandari | Sep 13, 2018 | News
September 13, 2018, Vancouver, B.C. – Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas” or the “Company”) is pleased to announce that 3 Carbon Extractions Inc. (“3 CARBON”), an industry leader in regulatory compliant cannabis hydrocarbon...
by Sam Eskandari | Sep 13, 2018 | News
VANCOUVER, British Columbia, Sept. 13, 2018 — Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas” or the “Company”) is pleased to announce that the Company has entered into a Non-Binding Letter of Intent (“LOI”) to sell all of the issued...